Latest Continuous Disclosure News

Page 11 of 71
Spenda Limited (ASX: SPX) has voluntarily suspended trading of its shares from 2 June 2026 to manage disclosure around its institutional accelerated renounceable entitlement offer (AREO). The suspension is expected to last until 10 June or until the AREO results are announced.
Claire Turing
Claire Turing
2 June 2026
The a2 Milk Company (ASX:A2M) has denied any undisclosed material information following a sharp share price drop and increased trading volumes, attributing market moves to a recent analyst downgrade citing supply chain uncertainties.
Victor Sage
Victor Sage
2 June 2026
a2 Milk confirms no undisclosed information behind recent share price moves, attributing volatility to a CLSA downgrade citing supply delays and previously disclosed risks.
Victor Sage
Victor Sage
1 June 2026
VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for eight of its Australian ETFs, detailing investment strategies, fees, risks, and operational protocols under ASX AQUA Rules.
Claire Turing
Claire Turing
1 June 2026
IDP Education (ASX:IEL) has responded to an ASX price query following a sharp share price fall and increased trading volume, attributing the movement to a late analyst downgrade and confirming compliance with continuous disclosure rules.
Victor Sage
Victor Sage
29 May 2026
Bass Oil Limited offers up to 24 million free attaching options to recent placement participants, alongside nearly 8 million options to its lead manager PAC Partners, with no new funds raised from the options issue.
Maxwell Dee
Maxwell Dee
29 May 2026
Immuron Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but pointing to a recent CEO presentation as a possible driver.
Ada Torres
Ada Torres
28 May 2026
Nexalis Therapeutics has locked in a $53 million non-dilutive funding facility with Point8 Capital, replacing its previous lender and supporting three clinical programs targeting breakthrough cancer pain, panic disorder, and treatment-resistant depression.
Ada Torres
Ada Torres
28 May 2026
Li-FT Power Ltd. has released an extensive update to its Corporate Governance Statement, outlining its board structure, committee roles, and compliance with Canadian and ASX governance standards. The company highlights partial adherence to some ASX recommendations, reflecting its current development stage.
Maxwell Dee
Maxwell Dee
28 May 2026
AoFrio Limited is offering existing shareholders a 1-for-7 rights issue at NZ$0.07 per share following a NZ$4.56 million placement, aiming to raise nearly NZ$5 million to fund growth ambitions.
Victor Sage
Victor Sage
27 May 2026
Phoslock Environmental Technologies reported a sales recovery in 2025 with further growth expected, backed by resumed production in China and promising European projects, while ongoing litigation clouds the outlook.
Maxwell Dee
Maxwell Dee
27 May 2026
Nexalis Therapeutics (ASX: NX1) has voluntarily suspended trading of its shares pending a material announcement on its existing debt funding facility, extending a recent trading halt. The suspension is set to last until the earlier of the announcement release or resumption of trading on 28 May 2026.
Ada Torres
Ada Torres
26 May 2026

Browse the archive

Full archive